Serum microRNAs as Diagnostic Markers in Polycystic Ovary Syndrome: A Narrative Review

被引:0
|
作者
Lavanya, K. [1 ]
Palaniappan, N. [2 ]
Vinodhini, V. M. [3 ]
Silambanan, Santhi [1 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Dept Biochem, Chennai 600116, Tamil Nadu, India
[2] Sri Ramachandra Inst Higher Educ & Res, Dept Obstet & Gynaecol, Chennai, Tamil Nadu, India
[3] SRM Med Coll Hosp & Res Ctr, Dept Biochem, Chennai, Tamil Nadu, India
关键词
Anovulation; Apoptosis; Biomarkers; Hormones; Hyperandrogenism; CIRCULATING MICRORNAS; CELL-PROLIFERATION; GENE-EXPRESSION; IDENTIFICATION; WOMEN; BIOMARKERS; RECEPTOR; PROFILE; PCOS;
D O I
10.7860/JCDR/2025/74412.20507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic Ovarian Syndrome (PCOS) is thought to be common worldwide among middle-aged women. Increased androgen production, recurrent anovulatory cycles and ovaries with multiple cysts are symptoms of this multiorgan endocrine condition. MicroRNAs (miRs) and several candidate genes, including CYP11A, CYP21 and CYP17, have been linked to PCOS. Singlestranded non coding RNAs known as microRNAs have been shown to alter several cell cycle processes, including metabolism, apoptosis, differentiation and proliferation. By targeting hormone receptors and their release, microRNAs influence the production of steroid hormones and play a significant role in the formation and regulation of follicular growth in the ovaries. Physiological development, including physical growth and embryonic development of the ovaries, alter the levels of microRNA expression. It has been discovered that the altered pattern of microRNAs under pathological circumstances is specific to certain disorders. Therefore, a variety of medications that are either agonists or antagonists of microRNAs may be useful in initiating tailored treatments. The profiles of microRNAs differ depending on the tissue from which they originate. Due to ribozyme activity, microRNAs are persistent and resistant to hydrolysis. Since serum microRNAs are present in various bodily fluids, they are novel markers for diseases like PCOS. The microRNA profile constantly changes depending on the pathogenic stage of the disease. There are correlations between the levels of established biomarkers and the up- and down-regulation of certain microRNAs. Furthermore, it has been found that microRNAs are more specific and sensitive than conventional biomarkers. This article was created to address the altered microRNA profiles in systemic circulation and in different ovarian tissues.
引用
收藏
页码:BE1 / BE6
页数:6
相关论文
共 50 条
  • [21] The Impact of Microparticulate Air Pollution in Polycystic Ovary Syndrome: A Narrative Review
    Stegehuis, Narelle
    Kotsirilos, Vicki
    Parker, Jim
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (10):
  • [22] Possible cognition changes in women with polycystic ovary syndrome: a narrative review
    Naz, Marzieh Saei Ghare
    Rahnemaei, Fatemeh Alsadat
    Tehrani, Fahimeh Ramezani
    Sayehmiri, Fatemeh
    Ghasemi, Vida
    Banaei, Mojdeh
    Ozgoli, Giti
    OBSTETRICS & GYNECOLOGY SCIENCE, 2023, 66 (05) : 347 - 363
  • [23] Diagnostic accuracy of biochemical markers for diagnosis polycystic ovary syndrome in reproductive women
    Mirjanic-Azaric, B.
    Soldat-Stankovic, V.
    Bogavac-Stanojevic, N.
    CLINICA CHIMICA ACTA, 2019, 493 : S345 - S345
  • [24] Diagnostic features of polycystic ovary syndrome
    Barday-Karbanee, N.
    Siebert, T. I.
    Botha, M. H.
    Kruger, T. F.
    SAJOG-SOUTH AFRICAN JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 12 (01): : 30 - 35
  • [25] Polycystic ovary syndrome - A diagnostic challenge
    Lewis, V
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (01) : 1 - +
  • [26] Diagnostic criteria in polycystic ovary syndrome
    Legro, RS
    SEMINARS IN REPRODUCTIVE MEDICINE, 2003, 21 (03) : 267 - 275
  • [27] Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
    Escobar-Morreale, Hector F.
    Luque-Ramirez, Manuel
    Gonzalez, Frank
    FERTILITY AND STERILITY, 2011, 95 (03) : 1048 - U249
  • [28] Association of Tumor Markers with Total Testosterone in the Serum of Women with Polycystic Ovary Syndrome
    Zhang, Jinghua
    Pan, Manman
    Zhang, Qing
    Wang, Fangfang
    Qu, Fan
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2022, 49 (07):
  • [29] Serum amyloid A in polycystic ovary syndrome
    Liu, Huiqing
    Meng, Xingqi
    Wang, Jinyuan
    Wei, Yi
    Tang, Jinru
    Lei, Xiaocan
    He, Weiguo
    Li, Suyun
    CLINICA CHIMICA ACTA, 2021, 518 : 151 - 155
  • [30] SERUM TESTOSTERONE IN POLYCYSTIC OVARY SYNDROME
    GIVEN, JR
    ANDERSEN, RN
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1975, 121 (08) : 1124 - 1125